Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
Nuclear Medicine and Biology
|
February 5, 2005
Backbone metal-cyclization: a novel approach for simultaneous peptide cyclization and radiolabeling. Application to the combinatorial synthesis of rhenium-cyclic somatostatin analogs
Gil Fridkin, Thomas A Bonasera, Pninit Litman, et al.
Pharmaceutics
|
June 27, 2024
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis
Shira Merzbach, Amnon Hoffman, Philip Lazarovici, et al.
Molecular Pharmaceutics
|
March 13, 2019
Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88
Shira Dishon, Adi Schumacher-Klinger, Chaim Gilon, et al.
Journal of Cell Science
|
October 25, 2003
Direct translocation of histone molecules across cell membranes
Elana Hariton-Gazal, Joseph Rosenbluh, Adolf Graessmann, et al.
Current Topics in Medicinal Chemistry
|
May 19, 2018
Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan - How to Do it Yourself!
Samuel J S Rubin, Yftah Tal-Gan, Chaim Gilon, et al.
Advances in Experimental Medicine and Biology
|
April 30, 2009
N-methylated cyclic pentapeptides as template structures
Jayanta Chatterjee, Oded Ovadia, Chaim Gilon, et al.
Bioorganic & Medicinal Chemistry
|
March 30, 2010
Synthesis and structure-activity relationship studies of peptidomimetic PKB/Akt inhibitors: the significance of backbone interactions
Yftah Tal-Gan, Noam S Freeman, Shoshana Klein, et al.
The Journal of Organic Chemistry
|
March 18, 2011
Microwave-assisted solid-phase aza-peptide synthesis: aza scan of a PKB/Akt inhibitor using aza-arginine and aza-proline precursors
Noam S Freeman, Yftah Tal-Gan, Shoshana Klein, et al.
Chemical Biology & Drug Design
|
August 10, 2011
Metabolic stability of peptidomimetics: N-methyl and aza heptapeptide analogs of a PKB/Akt inhibitor
Yftah Tal-Gan, Noam S Freeman, Shoshana Klein, et al.
Oncoscience
|
May 3, 2024
PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs
Jeetendra Kumar Nag, Amnon Hoffman, Chaim Gilon, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
Nuclear Medicine and Biology
|
February 5, 2005
Backbone metal-cyclization: a novel approach for simultaneous peptide cyclization and radiolabeling. Application to the combinatorial synthesis of rhenium-cyclic somatostatin analogs
Gil Fridkin, Thomas A Bonasera, Pninit Litman, et al.
Pharmaceutics
|
June 27, 2024
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis
Shira Merzbach, Amnon Hoffman, Philip Lazarovici, et al.
Molecular Pharmaceutics
|
March 13, 2019
Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88
Shira Dishon, Adi Schumacher-Klinger, Chaim Gilon, et al.
Journal of Cell Science
|
October 25, 2003
Direct translocation of histone molecules across cell membranes
Elana Hariton-Gazal, Joseph Rosenbluh, Adolf Graessmann, et al.
Current Topics in Medicinal Chemistry
|
May 19, 2018
Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan - How to Do it Yourself!
Samuel J S Rubin, Yftah Tal-Gan, Chaim Gilon, et al.
Advances in Experimental Medicine and Biology
|
April 30, 2009
N-methylated cyclic pentapeptides as template structures
Jayanta Chatterjee, Oded Ovadia, Chaim Gilon, et al.
Bioorganic & Medicinal Chemistry
|
March 30, 2010
Synthesis and structure-activity relationship studies of peptidomimetic PKB/Akt inhibitors: the significance of backbone interactions
Yftah Tal-Gan, Noam S Freeman, Shoshana Klein, et al.
The Journal of Organic Chemistry
|
March 18, 2011
Microwave-assisted solid-phase aza-peptide synthesis: aza scan of a PKB/Akt inhibitor using aza-arginine and aza-proline precursors
Noam S Freeman, Yftah Tal-Gan, Shoshana Klein, et al.
Chemical Biology & Drug Design
|
August 10, 2011
Metabolic stability of peptidomimetics: N-methyl and aza heptapeptide analogs of a PKB/Akt inhibitor
Yftah Tal-Gan, Noam S Freeman, Shoshana Klein, et al.
Oncoscience
|
May 3, 2024
PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs
Jeetendra Kumar Nag, Amnon Hoffman, Chaim Gilon, et al.
Page
of 8